Victoza launched
Novo Nordisk, launched Victoza(generic name: Liraglutide) for
treating adults with type 2 diabetes in Sri Lanka recently.
People with diabetes experience raised blood sugar because of either
a partial or complete reduction of insulin production in their body.
The two types of diabetes that is prevalent in patients are type 1
and type 2. Most people with diabetes (90-95 percent) have type 2, where
the pancreas produces insufficient quantities of insulin and/or the
insulin has a reduced effect on the muscle and liver cells for
regulating blood sugar levels.
Prevalence of diabetes in adults over 20 years
One in five adults suffer from either diabetes or pre-diabetes and
one-third of those with diabetes are undiagnosed.
"Victoza(r)" is Novo Nordisk's treatment for type 2 diabetes
mellitus, . Almost half of the patients currently on medication for type
2 diabetes fail to achieve healthy blood sugar levels.
For patients with type 2 diabetes who are not able to achieve healthy
blood sugar levels with common first-line drug (metformin), treatment
with Victoza(r) provides a number of benefits including reduction in
blood sugar levels" said Dr Srishyla, who heads medical affairs at Novo
Nordisk for their Sri Lankan operations.
|